Literature DB >> 14228538

RESISTANCE TO HUMAN GROWTH HORMONE IN PITUITARY DWARFISM: CLINICAL AND IMMUNOLOGIC STUDIES.

M L PARKER, I K MARIZ, W H DAUGHADAY.   

Abstract

Entities:  

Keywords:  ADOLESCENCE; ANTIBODIES; CHILD; DRUG THERAPY; DWARFISM, PITUITARY; PHARMACOLOGY; SOMATOTROPIN

Mesh:

Substances:

Year:  1964        PMID: 14228538     DOI: 10.1210/jcem-24-10-997

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  10 in total

1.  RADIOIMMUNOASSAY OF HUMAN PLASMA THYROTROPIN.

Authors:  R D UTIGER
Journal:  J Clin Invest       Date:  1965-08       Impact factor: 14.808

2.  Medical Research Council of Canada therapeutic trial of human growth hormone: first 5 years of therapy.

Authors:  H Guyda; H Friesen; J D Bailey; G Leboeuf; J C Beck
Journal:  Can Med Assoc J       Date:  1975-06-07       Impact factor: 8.262

3.  Short stature and its treatment.

Authors:  A S Mason
Journal:  Br Med J       Date:  1972-05-27

Review 4.  The Gordon Wilson lecture: growth hormone--1966.

Authors:  E B Astwood
Journal:  Trans Am Clin Climatol Assoc       Date:  1967

Review 5.  Dwarfism, hypopituitarism, and growth hormone.

Authors:  A Prader
Journal:  Arch Dis Child       Date:  1967-06       Impact factor: 3.791

6.  Treatment with growth hormone.

Authors: 
Journal:  Br Med J       Date:  1971-09-04

7.  Incidence and effects on growth of antibodies to human growth hormone.

Authors:  S R Chalkley; J M Tanner
Journal:  Arch Dis Child       Date:  1971-04       Impact factor: 3.791

8.  Hypopituitary dwarfism.

Authors:  G H Newns
Journal:  Proc R Soc Med       Date:  1967-07-07

9.  Calcitonin resistance: clinical and immunologic studies in subjects with Paget's disease of bone treated with porcine and salmon calcitonins.

Authors:  J G Haddad; J G Caldwell
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808

10.  An evaluation of antibodies and clinical resistance to salmon calcitonin.

Authors:  F R Singer; J P Aldred; R M Neer; S M Krane; J T Potts; K J Bloch
Journal:  J Clin Invest       Date:  1972-09       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.